Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry.
The antibody to the metal-binding low molecular weight protein metallothionein (MT) stains preferentially the proliferative edge of epithelial tumors in paraffin sections.
APA
Meskel HH, Cherian MG, et al. (1993). Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 6(6), 755-60.
MLA
Meskel HH, et al.. "Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry.." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 6, no. 6, 1993, pp. 755-60.
PMID
8302819
Abstract
The antibody to the metal-binding low molecular weight protein metallothionein (MT) stains preferentially the proliferative edge of epithelial tumors in paraffin sections. The present report demonstrates its usefulness as an epithelial cell marker in DNA flow cytometry of archival specimens. Nine control breast (mammoplasty) specimens, 10 control colonic specimens (resection edges), 12 adenocarcinomas of breast, and 13 adenocarcinomas of colon were analyzed by DNA flow cytometry after MT and DNA staining. The average percentage of cells stained by MT ranged from 12% to 27% in these groups of specimens, which contain epithelial as well as stromal and inflammatory cells. Comparing cell turnover, measured as S-phase fraction (SPF) in unstained and MT-stained preparations, it was 10% and 20%, respectively, in control tissues and 10% and 30%, respectively, in adenocarcinomas. The SPF is lower in unstained preparations because of dilution by noncycling inflammatory and stromal cells. Immunohistochemical staining of various tissues for MT showed specific staining of epithelial cells. Evaluation of aneuploid malignant epithelial cells detected in six breast and eight colonic adenocarcinomas showed that on average, 47% of cells were stained with MT and that their SPF increased by about 50% when MT staining was compared with the unstained preparations. The results suggest that MT stains epithelial cells adequately for ploidy and cell cycle evaluation and that it may stain preferentially the proliferating cell compartment, which is considered to be an index of malignancy.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 3 | |
| 시술 | mammoplasty
|
유방성형술 | dict | 1 | |
| 해부 | epithelial
|
scispacy | 1 | ||
| 해부 | compartment
|
scispacy | 1 | ||
| 해부 | DNA
|
scispacy | 1 | ||
| 해부 | epithelial cell
|
scispacy | 1 | ||
| 해부 | colon
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | stromal
|
scispacy | 1 | ||
| 해부 | inflammatory cells
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | S-phase
|
scispacy | 1 | ||
| 해부 | tissues
|
scispacy | 1 | ||
| 해부 | stromal cells
|
scispacy | 1 | ||
| 해부 | epithelial cells
|
scispacy | 1 | ||
| 질환 | tumors
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | adenocarcinomas
|
C0001418
Adenocarcinoma
|
scispacy | 1 | |
| 질환 | malignancy
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | epithelial tumors
|
scispacy | 1 | ||
| 질환 | paraffin sections
|
scispacy | 1 | ||
| 질환 | archival specimens
|
scispacy | 1 | ||
| 질환 | colonic specimens
|
scispacy | 1 | ||
| 질환 | specimens
|
scispacy | 1 | ||
| 질환 | aneuploid malignant epithelial cells
|
scispacy | 1 | ||
| 질환 | colonic adenocarcinomas
|
scispacy | 1 | ||
| 기타 | SPF
→ S-phase fraction
|
scispacy | 1 | ||
| 기타 | MT stains epithelial
|
scispacy | 1 |
MeSH Terms
Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Cell Compartmentation; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Epithelium; Female; Flow Cytometry; Humans; Metallothionein
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.